Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S067 - What's New in Dermatology

Tuesday, February 20; 8:00 AM - 10:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify cutaneous manifestations of viral diseases more effectively.
  • Select optimal therapies for patients with a number of cutaneous disorders including psoriasis, atopic dermatitis, chronic urticaria, and others.
  • Diagnose and treat disorders in patients with skin of color more effectively.

Description

Topics to be covered include identification of cutaneous manifestations of mosquito-borne viral diseases and an update on new vaccines and therapies for infectious diseases; updates in dermatopathology; updates in the diagnosis and treatment of disorders in skin of color; updates on surgical and cosmetic procedures; and updates on the new therapies available for pediatric and adult skin disease.

Disclosures

  • Butterwick, Kimberly J., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(H); Colorescience – A(H); Galderma Laboratories, L.P. – A(H); Merz Pharmaceuticals, LLC – A(H); Revance Therapeutics, Inc. – A(H); ThermiAesthetics – C(H); Valeant Pharmaceuticals International – C(H);
  • Desai, Seemal R., MD: AbbVie – C(Fees), I(Grants/Research Funding), SP(H); Allergan, Inc – C(Fees); Anacor Pharmaceuticals, Inc. – C(Fees); Dermira – I(Grants/Research Funding); Dr. Reddy – I(Grants/Research Funding); Ferndale Laboratories, Inc. – A(Fees); Foamix – I(Grants/Research Funding); Galderma Laboratories, LP – C(Fees), SP(H); Innovaderm Research Inc. – I(Grants/Research Funding); Menlo Therapeutics – C(H), I(Grants/Research Funding); Novan – I(Grants/Research Funding); Par Pharmaceutical – I(Grants/Research Funding); Pfizer Inc. – SP(H); Ralexar Therapeutics, Inc – I(Grants/Research Funding); Symbio – I(Grants/Research Funding); Valeant Pharmaceuticals North America LLC – C(Fees), SP(H);
  • Eichenfield, Lawrence F., MD: Allergan, Inc – C(H), I(Fees); Anacor Pharmaceuticals, Inc. – C(H); Cutanea Life Sciences – C(H); Dr. Reddy – C(H); DS Laboratories – C(H); Elsevier Inc. – O(IP); Galderma Laboratories, L.P. – C(H), I(Fees); Genentech, Inc. – C(H); Kimberly Clark – I(Fees); LEO Pharma, US – C(H), I(Fees); Lilly ICOS LLC – C(H); Medimetriks Pharmaceuticals, Inc. – C(H); Novan – C(H), I(Fees); Otsuka Pharmaceutical Co., Ltd. – C(H); Pfizer Inc. – C(H); Ralexar Therapeutics, Inc – C(H); Sanofi/Regeneron – C(H), I(Fees); Tioga Pharmaceuticals, Inc. – C(H); TopMD – C(SO); Valeant Pharmaceuticals International – C(H); Valeant Pharmaceuticals North America LLC – I(Fees); Wiley-Blackwell – O(H);
  • Elston, Dirk Michael, MD: no financial relationships exist with commercial interests.
  • Lebwohl, Mark, MD: AbbVie – I(Grants/Research Funding); Allergan, Inc. – C(H); Aqua – C(H); AstraZeneca – I(Grants/Research Funding); Boehringer Ingelheim – C(H); Celgene Corporation – I(Grants/Research Funding); Corrona, Inc. – O(H); Dr. Reddy – C(H); Eli Lilly and Company – I(Grants/Research Funding); Foundation for Research & Education of Dermatology – O(H); Incyte Corporation – I(Grants/Research Funding); Janssen Research & Development, LLC – I(Grants/Research Funding); Leo Pharma Inc – C(H); Medimmune – I(Grants/Research Funding); Menlo Therapeutics – C(H); Mitsibushi Pharma – C(H); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); SCIderm – I(Grants/Research Funding); Theravance Biopharma – C(H); Valeant Pharmaceuticals North America LLC – I(Grants/Research Funding); Vidac Pharma – I(Grants/Research Funding);
  • Ratner, Desiree, MD: no financial relationships exist with commercial interests.
  • Tomecki, Kenneth J., MD: no financial relationships exist with commercial interests.
Schedule
Tuesday, February 20
8:00 AM
Dr. Lebwohl / Introduction
8:04 AM
Dr. Tomecki / What's New in Infectious Disease
8:20 AM
Dr. Desai / What's New in Skin of Color
8:36 AM
Dr. Ratner / What's New in Surgical Dermatology
8:52 AM
Dr. Butterwick / What's New in Cosmetic Dermatology
9:08 AM
Dr. Eichenfield / What's New in Pediatric Dermatology
9:24 AM
Dr. Elston / What's New in Dermatopathology
9:40 AM
Dr. Lebwohl / What's New in Medical Dermatologic Therapy
Event Details
  • Date
    Tuesday, February 20
  • Time
    8:00 AM - 10:00 AM
  • Location
    Room 6B
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
Speakers
  • Desiree Ratner, MD, FAAD
  • Dirk Michael Elston, MD, FAAD
  • Kenneth J. Tomecki, MD, FAAD
  • Kimberly J. Butterwick, MD, FAAD
  • Lawrence F. Eichenfield, MD, FAAD
  • Seemal R. Desai, MD, FAAD